Clinical Trials on 神经内分泌肿瘤G2 in China
总计2308个结果
-
Peking Union Medical College Hospital招聘中
-
Peking University Cancer Hospital & Institute尚未招聘
-
Eye & ENT Hospital of Fudan UniversityCancer Institute and Hospital, Chinese Academy of Medical Sciences招聘中
-
Nanjing First Hospital, Nanjing Medical University招聘中
-
Loxo Oncology, Inc.Eli Lilly and Company主动,不招人
-
Shanghai Simnova Biotechnology Co.,Ltd.Shanghai Chest Hospital招聘中
-
Peking Union Medical College Hospital招聘中
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering Institute完全的
-
The Third Xiangya Hospital of Central South UniversityBeijing Capture Technology Co., Ltd未知
-
Fujian Maternity and Child Health Hospital招聘中
-
Peking Union Medical College Hospital完全的
-
Peking University Cancer Hospital & Institute招聘中
-
Innovent Biologics (Suzhou) Co. Ltd.终止
-
Peking Union Medical College Hospital完全的
-
Peking University Cancer Hospital & Institute招聘中
-
Pierre Fabre Medicament完全的黑色素瘤 | BRAF V600E 不可切除或转移性黑色素瘤 | BRAF V600E 转移性非小细胞肺癌中国
-
Mabwell (Shanghai) Bioscience Co., Ltd.完全的
-
Peking University Cancer Hospital & Institute招聘中
-
Novartis Pharmaceuticals完全的胰腺起源的晚期神经内分泌肿瘤加拿大, 法国, 英国, 台湾, 比利时, 西班牙, 荷兰, 美国, 意大利, 瑞典, 瑞士, 泰国, 德国, 希腊, 大韩民国, 日本, 巴西, 斯洛伐克
-
Peking University Cancer Hospital & Institute未知
-
Shandong TheraWisdom Biopharma Co., Ltd.招聘中
-
Eye & ENT Hospital of Fudan UniversityCancer Institute and Hospital, Chinese Academy of Medical Sciences招聘中